Three more western pharmaceutical companies have been drawn into widening Chinese probes into pricing and marketing practices in the drug industry, with Lundbeck and Novo Nordisk reporting recent inquiries from the authorities, and Sanofi investigating allegations made by a whistleblower.
随着manbetx3.0 扩大对医药行业定价和营销行为的调查，又有3家西方制药公司成为调查对象。灵北(Lundbeck)和诺和诺德(Novo Nordisk)称近期受到有关部门询问，而赛诺菲(Sanofi)对一名举报者的指控展开调查。
您已阅读14%（397字），剩余86%（2392字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。